Test quickly measures efficacy of Alzheimer's drugs

04/13/2009 | Belleville News-Democrat (Ill.)

Researchers said a new called stable isotope-lined kinetics can assess the efficacy of a drug for Alzheimer's disease in only 36 hours. The test was used to show that an Eli Lilly and Co. drug, which is in late-stage trials, reduced the production of amyloid beta. The test might also be used toward hastening the development of Alzheimer's drugs, the researchers said.

View Full Article in:

Belleville News-Democrat (Ill.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA